Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02053688Not ApplicableCompleted

Evaluation Study on Corneal Lens for Vision Correction

Role: lead

NCT01675375Not ApplicableCompleted

Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain

Role: lead

NCT00741624Phase 2Completed

Pain Reduce Following Refractive Surgery

Role: lead

NCT00691925Completed

Mitigating Pain Following Refractive Surgery

Role: lead

NCT00691847Completed

Reducing Edema Following Refractive Surgery

Role: lead

All 5 trials loaded